2023 Help me understand this report
Evaluation of PSMA target diagnostic PET tracers for therapeutic monitoring of [177Lu]ludotadipep of prostate cancer: Screening of PSMA target efficiency and biodistribution using [18F]DCFPyL and [68Ga]PSMA-11
Search citation statements
Paper Sections
Select...
Citation Types
0
1
0
Year Published
2023
2023
Publication Types
Select...
1
Relationship
0
1
Authors
Journals
Cited by 1 publication
(1 citation statement)
References 14 publications
0
1
0
“…At the same time, a performing radiopharmaceutical, 18 F/ 68 Ga-PSMA, is quickly becoming the most important agent for the imaging of prostate cancer and is considered as a preliminary step prior to submitting metastatic patients to radionuclide therapy with 177 Lu [ 16 ].…”
mentioning
confidence: 99%
“…At the same time, a performing radiopharmaceutical, 18 F/ 68 Ga-PSMA, is quickly becoming the most important agent for the imaging of prostate cancer and is considered as a preliminary step prior to submitting metastatic patients to radionuclide therapy with 177 Lu [ 16 ].…”
mentioning
confidence: 99%
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
